Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy (Copenhagen), 2020-05, Vol.75 (5), p.1023 [Peer Reviewed Journal]2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. ;EISSN: 1398-9995 ;DOI: 10.1111/all.14221 ;PMID: 32034960
Digital Resources/Online E-Resources
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||